| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2023―Oct―13 |
Cellular and humoral responses to fourth SARS-CoV-2 vaccination in a real-life cohort of patients with cancer |
Julia M. Berger, Pia Gattinger, Maximilian J. Mair, Anna S. Berghoff, Rudolf Valenta, Matthias Preusser |
| 2 |
[GO] |
2023―Jan―05 |
Vaccination against SARS-CoV-2 in adults with a diagnosis of cancer: a short review |
Waltraud Elisabeth Huf, Arschang Valipour |
| 3 |
[GO] |
2022―Jun―07 |
COVID-19 crisis and cancer |
Rupert Bartsch, Wolfgang Hilbe |
| 4 |
[GO] |
2022―Jun―07 |
COVID-19: New disease mechanism is simultaneously a therapeutic target |
Clemens A. Schmitt |
| 5 |
[GO] |
2022―May―06 |
High mortality in patients with active malignancy and severe COVID-19 |
Simon Udovica, Nino Müser, Agnes Pechlaner, Andreas Reichinger, Christoph Aichinger, Kathrin Strasser-Weippl, et al. (+5) Holger Rumpold, Andreas Petzer, Ewald Wöll, Wolfgang Hilbe, Ercan Müldür |
| 6 |
[GO] |
2022―Apr―11 |
Cardiopulmonary sequelae of COVID-19 |
|
| 7 |
[GO] |
2021―Dec―09 |
The outcome of COVID-19 in patients with hematological malignancy |
Pınar Tığlıoğlu, Murat Albayrak, Mesut Tığlıoğlu, Hacer Berna Afacan Öztürk, Merih Reis Aras, Buğra Sağlam, Senem Maral |
| 8 |
[GO] |
2021―Sep―16 |
SARS-CoV-2 vaccination in patients with solid tumors or hematological malignancies: Is the pandemic over for fully vaccinated patients? |
Niklas Zojer |
| 9 |
[GO] |
2021―Aug―11 |
Chronic lymphocytic leukaemia-what is new and notable in 2021, with a special focus on COVID-19 |
Katharina T. Prochazka, Peter Neumeister |
| 10 |
[GO] |
2021―Jun―15 |
Hemophagocytic lymphohistocytosis in a COVID-19 patient in the acute phase: case report |
Maher Salamoon, Mazen Kenj |
| 11 |
[GO] |
2020―Sep―21 |
Managing an oncology clinic during the COVID-19 pandemic-how we did it in Sarajevo? |
Semir Beslija |
| 12 |
[GO] |
2020―May―07 |
Circumnavigating the challenges of COVID-19 in oncology |
Thorsten Fuereder, Eberhard Gunsilius, Rupert Bartsch, Wolfgang Hilbe |
